Staff Reports
GRF presents Catalyst Award to philanthropists at annual gala
Glaucoma Research Foundation (GRF) honored leaders in areas of philanthropy, business, and medicine who have been instrumental in “developing a cure for glaucoma” during Thursday night’s Glaucoma 360 annual Gala.
Upcoming event: Alma Lasers to highlight aesthetic advances at ASLMS
Industry experts will discuss lasers and technological breakthroughs in aesthetics April 4 at 6:30 p.m. in downtown Phoenix. The forum will be held as a part of the 34th American Society for Laser Medicine and Surgery (ASLMS) Annual Conference.
Daylight, outdoor time linked to myopia
Two new studies add to the growing evidence that spending time outdoors may help prevent or minimize myopia in children.
AAO: Dangers of eyelash extensions
Cosmetic eyelash extensions and the adhesives used to apply them to eyelids can present dangers to consumers.
Draft bill gives FDA oversight of sterile compounding manufacturers
Legislation would create a new class of drug makers and strengthen FDA oversight
FDA warns of retinal abnormalities with Potiga use
Discoloration of skin and retina color have been reported
Glutamine, antioxidants not useful in critically ill patients, study shows
For critically ill adults with multiorgan failure, early supplementation with glutamine or antioxidants does not improve clinical outcomes, and glutamine may increase the mortality rate of this patient population, according to a study published in the April 18 issue of the New England Journal of Medicine.
L-carnitine therapy boosts cardiac health following heart attack, study reports
L-carnitine significantly improves cardiac health in patients after a heart attack, according to a multicenter team of investigators in a study published in Mayo Clinic Proceedings.
ApotheCure and NuVision compounding pharmacies recall all lots of sterile products
The companies' voluntary national recalls are based in sterility assurance concerns
Generics help to balance specialty pharmacy costs, report states
The increase in utilization of generic drugs is driving costs down, while the increase in specialty pharmacy utilization is driving costs up, according to the 2013 CVS Caremark annual Insights Report.